Thomas Hackenbeck
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Biochemistry top 10%
- Lipid metabolism and biosynthesis
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
-
- SARS-CoV-2 detection and testing 2
- Co-authors
- Michael Sean Wiesener (10 shared papers)Kai‐Uwe Eckardt (9 shared papers)Christina Warnecke (7 shared papers)Karl Xaver Knaup (8 shared papers)Kerstin Amann (6 shared papers)Johannes Schödel (3 shared papers)Carsten Willam (5 shared papers)Ruth Elisabeth Schietke (5 shared papers)
- Journals
- Kidney International (2 papers)Viruses (1 paper)American Journal Of Pathology (1 paper)BioTechniques (1 paper)PLoS ONE (1 paper)
- Partner nations
- GermanyFranceUnited Kingdom
In The Last Decade
Thomas Hackenbeck
14 papers receiving 608 citations
Peers
Comparison fields: 5 of 45
- Cancer Research 94
- Biochemistry 23
- Nephrology 47
- Genetics 65
- Infectious Diseases 42
Countries citing papers authored by Thomas Hackenbeck
This map shows the geographic impact of Thomas Hackenbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hackenbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hackenbeck more than expected).
Fields of papers citing papers by Thomas Hackenbeck
This network shows the impact of papers produced by Thomas Hackenbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hackenbeck. The network helps show where Thomas Hackenbeck may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Hackenbeck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 135 | |
| 2 | 2014 | 78 | |
| 3 | 2012 | 76 | |
| 4 | 2009 | 55 | |
| 5 | 2007 | 51 | |
| 6 | 2008 | 43 | |
| 7 | 2013 | 28 | |
| 8 | 2018 | 28 | |
| 9 | 2010 | 27 | |
| 10 | 2015 | 26 | |
| 11 | 2022 | 24 | |
| 12 | 2024 | 20 | |
| 13 | 2013 | 16 | |
| 14 | 2003 | 9 |
About Thomas Hackenbeck
Thomas Hackenbeck is a scholar working on Cancer Research, Infectious Diseases, Genetics, Nephrology and Molecular Biology, having authored 14 papers that have together received 616 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Genetic and Kidney Cyst Diseases (2 papers), SARS-CoV-2 detection and testing (2 papers), Renal and related cancers (1 paper), Cell death mechanisms and regulation (1 paper), Molecular Biology Techniques and Applications (1 paper) and Renal Diseases and Glomerulopathies (1 paper). The work is most often cited by research in Cancer Research (94 citations), Biochemistry (23 citations), Nephrology (47 citations), Genetics (65 citations) and Infectious Diseases (42 citations). Thomas Hackenbeck has collaborated with scholars based in Germany, France and United Kingdom. Frequent co-authors include Michael Sean Wiesener, Kai‐Uwe Eckardt, Christina Warnecke, Karl Xaver Knaup, Kerstin Amann, Johannes Schödel, Carsten Willam, Ruth Elisabeth Schietke, Xiaoqing Wu and Bernd Klanke. Their work appears in journals such as Kidney International, Viruses, American Journal Of Pathology, BioTechniques and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.